Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / DR Healthcare - biotexia

Clinicaltrial registered13 Nov 2026

DR Healthcare - biotexia

13 Nov 2026: Trial registered · Effect of Oral Diamine Oxidase on Symptoms Induced by Histamine Oral Challenge. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
13 Nov 2026
Title
Effect of Oral Diamine Oxidase on Symptoms Induced by Histamine Oral Challenge
Conditions
Histamine Intolerance, Food Hypersensitivity, Histamine Sensitivity, DAO Deficiency
Phase
Not applicable
Study Type
Interventional
Status
Recruiting
Countries
Spain
Country
Spain
Reference
NCT07934953
Location
Spain
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at DR Healthcare - biotexia

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Spain

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.